Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
     L01A ALKYLATING AGENTS
     L01B ANTIMETABOLITES
     L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
     L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
     L01E PROTEIN KINASE INHIBITORS
     L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
       L01FA CD20 (Clusters of Differentiation 20) inhibitors
       L01FB CD22 (Clusters of Differentiation 22) inhibitors
       L01FC CD38 (Clusters of Differentiation 38) inhibitors
       L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
         L01FD01 Trastuzumab
         L01FD02 Pertuzumab
         L01FD03 Trastuzumab emtansine
           D09980  Trastuzumab emtansine (USAN/INN) <JP/US>
         L01FD04 Trastuzumab deruxtecan
         L01FD05 Trastuzumab duocarmazine
         L01FD06 Margetuximab
         L01FD07 Zanidatamab
       L01FE EGFR (Epidermal Growth Factor Receptor) inhibitors
       L01FF PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors
       L01FG VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors
       L01FX Other monoclonal antibodies and antibody drug conjugates
       L01FY Combinations of monoclonal antibodies and antibody drug conjugates
     L01X OTHER ANTINEOPLASTIC AGENTS
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 2, 2025
According to WHO's ATC 2025

» Japanese version